Laboratory Of Stock EBITDA

LH Stock

USD 199.45 0.52 0.26%

Laboratory of fundamentals help investors to digest information that contributes to Laboratory's financial success or failures. It also enables traders to predict the movement of Laboratory Stock. The fundamental analysis module provides a way to measure Laboratory's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Laboratory stock.

		Last Reported	Projected for Next Year
	EBITDA	1.7 B	1.1 B

The current EBITDA is estimated to decrease to about 1.1 B.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Laboratory of Company EBITDA Analysis

Laboratory's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Laboratory EBITDA

1.7 B

Most of Laboratory's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Laboratory of is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Laboratory EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Laboratory is extremely important. It helps to project a fair market value of Laboratory Stock properly, considering its historical fundamentals such as EBITDA. Since Laboratory's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Laboratory's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Laboratory's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.93	0.95	0.92	0.96	0.98	0.94	0.9	-0.01	0.57	0.84	0.9	0.94	-0.73	0.31	0.8	-0.34	0.91	-0.44	0.54	-0.48	0.1	0.45	0.53	0.49	-0.68
Total Stockholder Equity	0.98		0.84	0.98	0.92	0.99	0.92	0.97	0.83	0.0	0.48	0.73	0.92	0.89	-0.66	0.37	0.85	-0.16	0.82	-0.57	0.44	-0.5	0.09	0.53	0.63	0.59	-0.78
Net Debt	0.93	0.84		0.78	0.88	0.78	0.97	0.75	0.92	0.0	0.61	0.91	0.8	0.91	-0.74	0.11	0.65	-0.63	0.97	-0.22	0.67	-0.48	0.19	0.13	0.27	0.17	-0.49
Retained Earnings	0.95	0.98	0.78		0.89	0.98	0.87	0.96	0.77	0.04	0.54	0.66	0.89	0.84	-0.7	0.36	0.81	-0.05	0.74	-0.57	0.3	-0.4	0.05	0.54	0.66	0.61	-0.8
Accounts Payable	0.92	0.92	0.88	0.89		0.87	0.88	0.85	0.76	0.13	0.54	0.68	0.93	0.8	-0.67	0.17	0.75	-0.23	0.82	-0.47	0.5	-0.65	0.35	0.23	0.47	0.27	-0.76
Net Receivables	0.96	0.99	0.78	0.98	0.87		0.89	0.98	0.8	-0.02	0.47	0.7	0.89	0.87	-0.64	0.46	0.84	-0.09	0.76	-0.58	0.39	-0.42	0.03	0.6	0.68	0.67	-0.77
Total Liab	0.98	0.92	0.97	0.87	0.88	0.89		0.87	0.93	-0.03	0.63	0.91	0.84	0.95	-0.77	0.24	0.71	-0.5	0.96	-0.3	0.62	-0.45	0.1	0.35	0.41	0.38	-0.56
Total Current Assets	0.94	0.97	0.75	0.96	0.85	0.98	0.87		0.75	-0.03	0.46	0.67	0.9	0.82	-0.62	0.47	0.83	-0.03	0.75	-0.58	0.41	-0.47	0.09	0.67	0.7	0.69	-0.78
Intangible Assets	0.9	0.83	0.92	0.77	0.76	0.8	0.93	0.75		-0.11	0.57	0.96	0.67	0.99	-0.71	0.21	0.63	-0.61	0.94	-0.17	0.6	-0.29	-0.12	0.22	0.21	0.38	-0.35
Short Term Debt	-0.01	0.0	0.0	0.04	0.13	-0.02	-0.03	-0.03	-0.11		0.26	-0.22	0.15	-0.16	-0.17	-0.07	-0.32	0.2	-0.12	-0.01	-0.1	-0.28	0.5	-0.06	0.03	-0.24	-0.25
Common Stock	0.57	0.48	0.61	0.54	0.54	0.47	0.63	0.46	0.57	0.26		0.58	0.39	0.54	-0.97	-0.15	0.03	-0.33	0.57	0.29	0.16	-0.07	0.07	0.1	0.12	0.11	-0.2
Long Term Debt	0.84	0.73	0.91	0.66	0.68	0.7	0.91	0.67	0.96	-0.22	0.58		0.57	0.95	-0.7	0.12	0.54	-0.73	0.94	-0.02	0.7	-0.25	-0.17	0.18	0.14	0.31	-0.21
Property Plant Equipment	0.9	0.92	0.8	0.89	0.93	0.89	0.84	0.9	0.67	0.15	0.39	0.57		0.73	-0.54	0.33	0.83	-0.07	0.75	-0.68	0.45	-0.68	0.43	0.43	0.57	0.35	-0.9
Good Will	0.94	0.89	0.91	0.84	0.8	0.87	0.95	0.82	0.99	-0.16	0.54	0.95	0.73		-0.7	0.25	0.72	-0.53	0.93	-0.28	0.6	-0.3	-0.13	0.32	0.33	0.47	-0.45
Treasury Stock	-0.73	-0.66	-0.74	-0.7	-0.67	-0.64	-0.77	-0.62	-0.71	-0.17	-0.97	-0.7	-0.54	-0.7		0.03	-0.24	0.36	-0.69	-0.12	-0.23	0.12	-0.01	-0.21	-0.25	-0.25	0.33
Short Term Investments	0.31	0.37	0.11	0.36	0.17	0.46	0.24	0.47	0.21	-0.07	-0.15	0.12	0.33	0.25	0.03		0.46	0.2	0.13	-0.53	0.02	-0.01	-0.03	0.64	0.42	0.56	-0.36
Current Deferred Revenue	0.8	0.85	0.65	0.81	0.75	0.84	0.71	0.83	0.63	-0.32	0.03	0.54	0.83	0.72	-0.24	0.46		-0.06	0.66	-0.78	0.37	-0.47	0.08	0.47	0.58	0.52	-0.75
Net Tangible Assets	-0.34	-0.16	-0.63	-0.05	-0.23	-0.09	-0.5	-0.03	-0.61	0.2	-0.33	-0.73	-0.07	-0.53	0.36	0.2	-0.06		-0.64	-0.41	-0.62	0.05	0.11	0.37	0.36	0.29	-0.33
Long Term Debt Total	0.91	0.82	0.97	0.74	0.82	0.76	0.96	0.75	0.94	-0.12	0.57	0.94	0.75	0.93	-0.69	0.13	0.66	-0.64		-0.19	0.7	-0.5	0.1	0.2	0.17	0.24	-0.42
Capital Surpluse	-0.44	-0.57	-0.22	-0.57	-0.47	-0.58	-0.3	-0.58	-0.17	-0.01	0.29	-0.02	-0.68	-0.28	-0.12	-0.53	-0.78	-0.41	-0.19		-0.03	0.38	-0.23	-0.48	-0.58	-0.41	0.84
Deferred Long Term Liab	0.54	0.44	0.67	0.3	0.5	0.39	0.62	0.41	0.6	-0.1	0.16	0.7	0.45	0.6	-0.23	0.02	0.37	-0.62	0.7	-0.03		-0.55	0.15	0.01	0.0	0.04	-0.11
Long Term Investments	-0.48	-0.5	-0.48	-0.4	-0.65	-0.42	-0.45	-0.47	-0.29	-0.28	-0.07	-0.25	-0.68	-0.3	0.12	-0.01	-0.47	0.05	-0.5	0.38	-0.55		-0.64	-0.15	-0.2	0.01	0.56
Short Long Term Debt	0.1	0.09	0.19	0.05	0.35	0.03	0.1	0.09	-0.12	0.5	0.07	-0.17	0.43	-0.13	-0.01	-0.03	0.08	0.11	0.1	-0.23	0.15	-0.64		-0.16	0.01	-0.48	-0.46
Cash And Equivalents	0.45	0.53	0.13	0.54	0.23	0.6	0.35	0.67	0.22	-0.06	0.1	0.18	0.43	0.32	-0.21	0.64	0.47	0.37	0.2	-0.48	0.01	-0.15	-0.16		0.71	0.86	-0.48
Net Invested Capital	0.53	0.63	0.27	0.66	0.47	0.68	0.41	0.7	0.21	0.03	0.12	0.14	0.57	0.33	-0.25	0.42	0.58	0.36	0.17	-0.58	0.0	-0.2	0.01	0.71		0.69	-0.68
Net Working Capital	0.49	0.59	0.17	0.61	0.27	0.67	0.38	0.69	0.38	-0.24	0.11	0.31	0.35	0.47	-0.25	0.56	0.52	0.29	0.24	-0.41	0.04	0.01	-0.48	0.86	0.69		-0.37
Capital Stock	-0.68	-0.78	-0.49	-0.8	-0.76	-0.77	-0.56	-0.78	-0.35	-0.25	-0.2	-0.21	-0.9	-0.45	0.33	-0.36	-0.75	-0.33	-0.42	0.84	-0.11	0.56	-0.46	-0.48	-0.68	-0.37

Click cells to compare fundamentals

Laboratory EBITDA Historical Pattern

Today, most investors in Laboratory Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Laboratory's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Laboratory ebitda as a starting point in their analysis.

Laboratory EBITDA

Timeline

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Laboratory

Ebitda Over Time

Laboratory Ebitda

Ebitda

1.13 Billion

As of now, Laboratory's EBITDA is increasing as compared to previous years.

According to the company disclosure, Laboratory of reported earnings before interest,tax, depreciation and amortization of 1.7 B. This is 94.27% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 56.28% higher than that of the company.

Laboratory EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratory's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Laboratory could also be used in its relative valuation, which is a method of valuing Laboratory by comparing valuation metrics of similar companies.

Laboratory is currently under evaluation in ebitda category among related companies.

Laboratory ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Laboratory's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Laboratory's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Laboratory Institutional Holders

Institutional Holdings refers to the ownership stake in Laboratory that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Laboratory's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Laboratory's value.

		Shares
Norges Bank	2023-12-31	1.3 M
Bank Of America Corp	2023-12-31	1.3 M
Ubs Asset Mgmt Americas Inc	2023-12-31	1.2 M
Northern Trust Corp	2023-12-31	1.2 M
Veritas Investment Partners (uk) Ltd.	2023-12-31	1.1 M
Amvescap Plc.	2023-12-31	1.1 M
Fmr Inc	2023-12-31	1.1 M
Allspring Global Investments Holdings, Llc	2023-12-31	1 M
Nuveen Asset Management, Llc	2023-12-31	920.5 K
Blackrock Inc	2023-12-31	10.5 M
Vanguard Group Inc	2023-12-31	9.7 M

Laboratory Fundamentals

	Return On Equity	0.0423
	Return On Asset	0.0377
	Profit Margin	0.03 %
	Operating Margin	0.07 %
	Current Valuation	22.42 B
	Shares Outstanding	84.13 M
	Shares Owned By Insiders	0.33 %
	Shares Owned By Institutions	98.26 %
	Number Of Shares Shorted	1.92 M
	Price To Earning	12.69 X
	Price To Book	2.20 X
	Price To Sales	1.42 X
	Revenue	12.16 B
	Gross Profit	4.39 B
	EBITDA	1.7 B
	Net Income	379.2 M
	Cash And Equivalents	430 M
	Cash Per Share	4.63 X
	Total Debt	5.95 B
	Debt To Equity	0.63 %
	Current Ratio	1.73 X
	Book Value Per Share	93.86 X
	Cash Flow From Operations	1.33 B
	Short Ratio	2.49 X
	Earnings Per Share	4.32 X
	Price To Earnings To Growth	0.48 X
	Target Price	246.13
	Number Of Employees	56.95 K
	Beta	1.0
	Market Capitalization	16.97 B
	Total Asset	16.73 B
	Retained Earnings	7.89 B
	Working Capital	540.2 M
	Current Asset	585.1 M
	Current Liabilities	226.4 M
	Annual Yield	0.01 %
	Net Asset	16.73 B
	Last Dividend Paid	2.88

About Laboratory Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Laboratory of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratory using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratory of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Of Stock:

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Laboratory Piotroski F Score and Laboratory Altman Z Score analysis.

Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.

	AI Investment Finder Use AI to screen and filter profitable investment opportunities
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated

Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.46)

Dividend Share

2.88

Earnings Share

4.32

Revenue Per Share

139.628

Quarterly Revenue Growth

0.035

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Of Stock EBITDA

Laboratory of Company EBITDA Analysis

EBITDA

Revenue

-

Basic Expenses

Current Laboratory EBITDA

Laboratory EBITDA Driver Correlations

Laboratory EBITDA Historical Pattern

Laboratory Ebitda

Ebitda

1.13 Billion

Laboratory EBITDA Peer Comparison

Laboratory ESG Sustainability

Laboratory Institutional Holders

Laboratory Fundamentals

About Laboratory Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Laboratory Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY